Worth the switch? Enhancing process performance for cell therapy manufacturing with an animal component-free raw material strategy

Historically, cell therapies have relied heavily on animal- and human-derived components—but the variability associated with these sources can lead to inconsistency and safety concerns. In recent times, focus has shifted toward utilizing chemically-defined raw materials, including animal component-free proteins. This article explores the critical role raw materials play in process performance and highlights how animal component-free raw materials can enable optimized, reliable, and efficient cell therapy manufacturing.

Please enter your email to access content Read now